Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Table 4

Patients, timing of injections, and residual edema in OCT-3 injections group.

	3 injection first within 1 month	3 injection first within 2 months	3 injection first within 3 months	3 injection first after more than 3 months
No. of patients	15	8	9	7
No. of patients with residual edema in OCT	2	1	2	3